Patients that are immunosuppressed might be at risk of serious influenza-associated
complications. As a result, multiple guidelines recommend influenza vaccination for patients …

Since the introduction to the Swiss market in 1997, Crucell (former Berna Biotech Ltd.), has
sold over 41 million doses worldwide of the virosomal adjuvanted influenza vaccine …

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Co-infections contribute to HIV-related pathogenesis and often increase viral load in HIV-
infected people. We did a systematic review to assess the effect of treating key co-infections …

Background Yearly influenza vaccination, although recommended for human
immunodeficiency virus (HIV)–infected individuals, has not received thorough evaluation in …

Objective: To evaluate the safety and immunogenicity of the H1N1 2009 vaccine in HIV-
positive individuals. Design: A single-arm study. Setting: Clinic at the Hospital of the …

HIV/AIDS Programme Page 1 ESSENTIAL PREVENTION AND CARE INTERVENTIONS FOR
ADULTS AND ADOLESCENTS LIVING WITH HIV IN RESOURCE-LIMITED SETTINGS …

HIV-positive as well as other immunocompromised women and men have increased risk of
human papillomavirus (HPV)-associated anogenital and oral cancers. The effectiveness of a …

Background. Limited data exist on the immunogenicity of the 2009 influenza A (H1N1)
vaccine among immunocompromised persons, including those with human …

The article discusses the recommendations on the proper usage of active and passive
immunization in adults with (Human Immunodeficiency Virus) HIV. It explains HIV and …